In vivo synthesis of airway-active agents from arachidonic acid

E. W. Spannhake, J. L. Levin, D. B. McNamara, A. L. Hyman, P. J. Kadowitz

Research output: Contribution to journalArticle

Abstract

Evidence is presented that arachidonic acid can be metabolized, in vivo, to the full spectrum of bronchoactive cyclo-oxygenase products. The predominant activity which results in the healthy lung may vary as a function of several factors, including the quantity and location of available substrate and the pre-existing contractile state of the airways. Production of bronchoactive leukotrienes appears to be minimal in the healthy lung, but the relationship between these two alternative pathways of arachidonic acid metabolism appears to be different in sensitized animals.

Original languageEnglish (US)
Pages (from-to)523-530
Number of pages8
JournalClinical Respiratory Physiology
Volume17
Issue number4
StatePublished - Dec 1 1981
Externally publishedYes

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'In vivo synthesis of airway-active agents from arachidonic acid'. Together they form a unique fingerprint.

  • Cite this

    Spannhake, E. W., Levin, J. L., McNamara, D. B., Hyman, A. L., & Kadowitz, P. J. (1981). In vivo synthesis of airway-active agents from arachidonic acid. Clinical Respiratory Physiology, 17(4), 523-530.